Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...

Abbott NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that?A lot of things we commonly hear about ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Guilfoyle's career trajectory spans law, media, and politics. Starting as an assistant district attorney in San Francisco and ...